Real-Life Effectiveness of Mepolizumab on Forced Expiratory Flow between 25% and 75% of Forced Vital Capacity in Patients with Severe Eosinophilic Asthma

Severe eosinophilic asthma (SEA) is associated with high peripheral blood and airway eosinophilia, recurrent disease exacerbations and severe airflow limitation. Eosinophilic inflammation is also responsible for small airway disease (SAD) development. SEA patients experience poor disease control and...

Descripción completa

Detalles Bibliográficos
Autores principales: Maglio, Angelantonio, Vitale, Carolina, Pellegrino, Simona, Calabrese, Cecilia, D’Amato, Maria, Molino, Antonio, Pelaia, Corrado, Triggiani, Massimo, Pelaia, Girolamo, Stellato, Cristiana, Vatrella, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615088/
https://www.ncbi.nlm.nih.gov/pubmed/34829778
http://dx.doi.org/10.3390/biomedicines9111550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615088/
https://www.ncbi.nlm.nih.gov/pubmed/34829778
http://dx.doi.org/10.3390/biomedicines9111550

Ejemplares similares